Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. May 15, 2025; 17(5): 103809
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.103809
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.103809
Table 5 DeLong test results for the area under the curve of dynamic contrast-enhanced magnetic resonance imaging metrics and tumor biomarkers in differentiating T staging and degree of differentiation
Inspection results | Z-score | Significance level | AUC | Mean error | 95%CI |
T installment | |||||
CA19-9 and CA125 serum biomarkers | 0.862 | 0.389 | 0.014 | 0.016 | -0.018 to 0.046 |
CA19-9 alongside DCE-MRI measurements and cancer markers | 4.253 | < 0.05 | 0.111 | 0.026 | 0.060 to 0.162 |
CA125 in conjunction with DCE-MRI parameters and tumor markers | 4.682 | < 0.05 | 0.125 | 0.027 | 0.072 to 0.178 |
Degree of differentiation | |||||
CA19-9 and CA125 serum biomarkers | 0.923 | 0.356 | 0.018 | 0.020 | -0.021 to 0.057 |
CA19-9 alongside DCE-MRI measurements and cancer markers | 4.132 | < 0.05 | 0.109 | 0.026 | 0.058 to 0.160 |
CA125 in conjunction with DCE-MRI parameters and tumor markers | 4.521 | < 0.05 | 0.127 | 0.028 | 0.072 to 0.182 |
- Citation: Wang Q, Zhang XY, Yang JF, Tao YL. Comparison of dynamic contrast-enhanced-magnetic resonance imaging parameters and serum markers in preoperative rectal cancer evaluation: Combined diagnostic value. World J Gastrointest Oncol 2025; 17(5): 103809
- URL: https://www.wjgnet.com/1948-5204/full/v17/i5/103809.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i5.103809